Titre: Conference of the League of patients with renal cancer
Conditions de participation des participants:
Forfait d'inscription matériel de conférence,
SUJETS
Drugs for treatment of kidney cancer
Evaluating the effectiveness of treatment for kidney cancer. Side effects of therapy.
Criteria for evaluating the effectiveness of the drug: RECIST? Choi?
Common side effects of therapy for kidney cancer. The effects of targeted therapies on the cardiovascular system
Targeted drugs and haemostasis
Nesvetlokletochnogo treatment for kidney cancer
Alternative modes and drug regimens for renal cell carcinoma –
Treatment of elderly patients
A new classification of renal cell carcinoma TNM
Diagnosis of renal cancer
Surgical treatment of kidney cancer
Prognostic model for kidney cancer
Adjuvant therapy for kidney cancer
Discussion: The surgical and adjuvant treatment
Metastases of renal cancer in the bone
Surgical treatment of metastatic renal cell carcinoma
New in the medicinal treatment of metastatic renal cell carcinoma
VHL syndrome and renal cell carcinoma
The stability problem for kidney cancer targeted therapy
Cytoreductive nephrectomy value at the present stage
Drug treatment of metastatic renal cell carcinoma
Resistance to targeted therapy
Locally advanced RCC
Papillary renal cell carcinoma
New agents on the horizon
Small kidney tumor
Ablation
Treatment of particular groups of patients with metastatic RCC
for group discounts please contact us by email: confé[email protected]
Vols:
50 euros ( Sens Unique) : http://wizzair.com/?language=EN
Questions
Contactez NBScience
Département d’éducation/conférence:
Vous souhaitez savoir si les programmes cliniques actuels, développements de la recherche, ou des approches thérapeutiques émergentes peuvent être pertinentes à votre situation?
Informations pédagogiques et de recherche uniquement. Les décisions médicales individuelles doivent être prises en consultation avec des professionnels de santé qualifiés..
